am I the only one who found API source harder than the injections
Long-ish post, sorry. tl;dr at the bottom.
I have been tracking telehealth against ApoB for 23 weeks because I could not find anyone who had. The correlation is weaker than I expected, which is itself mildly interesting given how confidently people link the two in here.
Caveats up front: one person, one lab, one assay, no control, and I changed my training in the middle of it, which was stupid.
tl;dr: probably real, definitely smaller than the threads imply, and not worth reorganising your week around.
best — the order this archive was captured in
Strongly agree. API source transparency matters.
Did they tell you their API source or dodge the question?
regulatory claims need a citation to the actual rule, not interpretation
Three years on this site and the questions have not changed at all. Which is depressing or reassuring depending on the day.
Asked 20 compounders about API source. One told me, one dodged, one said they cannot say. The answer is the signal.
no pharmacy referral codes, naming is fine, recruiting is not
telehealth prescriber models exist, pricing differs by state
Strongly agree. API source transparency matters.
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
This is correct. The shortage list does expire and the rules change.
Disagree. What you are describing is consistent with 503B, not with what you concluded.
Disagree but this is the good kind of wrong — it is specific enough to be checked.
shortage list status is shortage list, check the actual list
telehealth costs API source plus compounding markup, total varies
the shortage list is temporary, it ends and compounding becomes illegal again
503B compounding is different from 503A, different rules, different legality
Strongly agree. API source transparency matters.
This is correct. The shortage list does expire and the rules change.
Not to be pedantic but 503A and shortage list are being used interchangeably and they are not interchangeable in real life.
The telehealth + compounding combo cost API source plus 11% markup. Not cheap but covered by insurance depending on state.
This is correct. The shortage list does expire and the rules change.
- 1Disagree. What you are describing is consistent with 503B, not with what you…7 comments in this branch · started by u/lukas_delgado